Protara Therapeutics (TARA) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Protara Therapeutics

· TARA

Dashboard

Financials

Ratios

Valuation

Statistics

189.697 M

-4.98%

Protara Therapeutics (TARA) Company Statistics | The Fly

General

Market Cap: $189.7M
Enterprise Value: $157.1M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -39.76%
ROE: -41.72%
ROIC: -46.81%
Current Ratio: 10.97
Debt-to-Equity: 0.02
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 1.06
EV/EBITDA: -2.25

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $76.7M
Operating Income: -$76.79M
Net Profit: -$70.02M

Balance Sheet

Cash and Equivalents: $17.08M
Working Capital: $132.83M
Total Assets: $176.09M
Net Debt: -$14.33M
Total Liabilities: $14.78M
Total Equity: $161.31M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$64.8M
Cash Flow from Investing: -$30.38M
Cash Flow from Financing: $80.68M
Free Cash Flow: -$65.16M
Capital Expenditures: $360K